GHRP-6
GHRP-6
Also known as: Growth Hormone Releasing Hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Overview
Key Facts
Primary Goal: A hexapeptide growth hormone secretagogue that acts on the ghrelin receptor to stimulate potent GH release
A hexapeptide growth hormone secretagogue that acts on the ghrelin receptor to stimulate potent GH release. It is notable for also strongly stimulating appetite through ghrelin pathway activation, making it useful where increased caloric intake is desired. Half-Life 15-60 minutes Typical Dose 100–300 mcg Frequency 2-3 times daily Cycle Length 8-16 weeks
Dosing Information
Half-Life
15-60 minutes
Typical Dose
100–300 mcg
Frequency
2-3 times daily
Cycle Length
8-16 weeks
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Research Summary
GHRP-6 was one of the first synthetic GH secretagogues developed, extensively studied since the 1980s. It has been shown to produce robust, dose-dependent GH release, though with less selectivity than newer GHRPs. Preclinical research has also identified cardioprotective properties, with studies showing reduced infarct size in animal models of myocardial ischemia.
Frequently Asked Questions
Common questions about GHRP-6
UK-Specific Information
Exclusive data points and guidance for UK residents using GHRP-6
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.